| POU2F1 |
POU2F1, OCT1, OTF1: POU domain, class 2, transcription factor 1 |
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
26.470 |
Evidence |
|
| CCND1 |
CCND1, BCL1, PRAD1: G1/S-specific cyclin-D1 |
CDKN1A |
CDKN1A, CAP20, CDKN1, CIP1, MDA6, PIC1, SDI1, WAF1: Cyclin-dependent kinase inhi |
26.470 |
Evidence |
O
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
26.470 |
Evidence |
|
| CDK2 |
CDK2: Cell division protein kinase 2 |
ORC2L |
ORC2L, ORC2: Origin recognition complex subunit 2 |
26.440 |
Evidence |
O
|
| PDHA1 |
PDHA1, PHE1A: Pyruvate dehydrogenase E1 component subunit alpha, somatic form, m |
PDK2 |
PDK2: [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 2, mitochondrial precu |
26.080 |
Evidence |
|
| CALM2 |
CALM1, CALM, CALM2, CAM2, CALM3, CALML2, CAM, CAMB, CAM3, CAM1, CAMC, CAMIII: Ca |
RELA |
RELA, NFKB3: Transcription factor p65 |
26.080 |
Evidence |
|
| HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
HDAC2 |
HDAC2: Histone deacetylase 2 |
26.080 |
Evidence |
O
|
| BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
HDAC2 |
HDAC2: Histone deacetylase 2 |
26.080 |
Evidence |
O
|
| COPE |
COPE: Coatomer subunit epsilon |
COPB2 |
COPB2: Coatomer subunit beta' |
26.080 |
Evidence |
|
| STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
PPP2CA |
PPP2CA: Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform |
26.010 |
Evidence |
|
| AXL |
AXL, UFO: Tyrosine-protein kinase receptor UFO precursor |
SHC3 |
SHC3, NSHC, SHCC: SHC-transforming protein 3 |
25.960 |
Evidence |
|
| ADPRT |
PARP1, ADPRT, PPOL: Poly [ADP-ribose] polymerase 1 |
WRN |
WRN, RECQ3, RECQL2: Werner syndrome ATP-dependent helicase |
25.910 |
Evidence |
|
| PTPN1 |
PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
25.790 |
Evidence |
|
| EPHA8 |
EPHA8, EEK, KIAA1459: Ephrin type-A receptor 8 precursor |
EFNA5 |
EFNA5, EPLG7, LERK7: Ephrin-A5 precursor |
25.660 |
Evidence |
O
|
| ACVR1B |
ACVR1B, ACVRLK4: Activin receptor type-1B precursor |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
25.660 |
Evidence |
|
| GYS1 |
GYS1, GYS: Glycogen [starch] synthase, muscle |
GYG1 |
GYG1, GYG: Glycogenin-1 |
25.510 |
Evidence |
|
| ITGB3 |
ITGB3, GP3A: Integrin beta-3 precursor |
PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
25.3 |
Evidence |
|
| FOS |
FOS, G0S7: Proto-oncogene protein c-fos |
ETS1 |
ETS1, EWSR2: Protein C-ets-1 |
25.3 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
IGF1R |
IGF1R: Insulin-like growth factor 1 receptor precursor |
25.3 |
Evidence |
|
| JUNB |
JUNB: Transcription factor jun-B |
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
25.3 |
Evidence |
O
|
| APEX1 |
APEX1, APE, APEX, APX, HAP1, REF1: DNA-(apurinic or apyrimidinic site) lyase |
CSNK2A1 |
CSNK2A1: CSNK2A1 protein |
25.090 |
Evidence |
|
| RB1 |
RB1: Retinoblastoma-associated protein |
CDK4 |
CDK4: Cell division protein kinase 4 |
25.060 |
Evidence |
O
|
| PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
PRKCZ |
PRKCZ, PKC2: Protein kinase C zeta type |
25.040 |
Evidence |
|
| PRKCI |
PRKCI, DXS1179E: Protein kinase C iota type |
YWHAZ |
YWHAZ: 14-3-3 protein zeta/delta |
25.040 |
Evidence |
|
| CDK4 |
CDK4: Cell division protein kinase 4 |
CCND2 |
CCND2: G1/S-specific cyclin-D2 |
25.030 |
Evidence |
O
|
